Bioinformatics Analysis of TIMP1, HK2 and IGFBP7 as Potential Biomarkers and Therapeutic Targets of Paclitaxel Resistance in Breast Cancer

Background: Paclitaxel is widely used as an adjuvant therapy in the treatment of breast cancer, yet its effectiveness decreases due to resistance problems. We conducted the present study to identify the potential paclitaxel resistance biomarkers and therapeutic targets in breast cancer employing bio...

Full description

Bibliographic Details
Main Authors: Adam Hermawan, Herwandhani Putri
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2021-04-01
Series:Middle East Journal of Cancer
Subjects:
Online Access:https://mejc.sums.ac.ir/article_47024_ed57f4dd18cbd5ed95c820189c7be826.pdf